Skip to main content
. 2020 Oct 31;12(11):3211. doi: 10.3390/cancers12113211

Figure 3.

Figure 3

(A) The drug encapsulation efficiency of CPT-11 (single drug), panobinostat (single drug) or CPT-11 + panobinostat (dual drug) in immunoliposomes (n = 5). (B) The drug release profiles from CPT-11 and panobinostat-loaded immunoliposomes (ImmuLipCP) at 37 °C in PBS (pH 7.4) (n = 5).